Insights - Radiopharmaceutical companies are primed for increased investor interest as the sector is seeing meaningful progress that is currently being overlooked in favor of ADCs. Tailwinds … Continue Reading
Read nowTranscripts - Operator Good morning, and welcome to the BioXcel Therapeutics TRANQUILITY II Top Line Results Conference Call. [Operator Instructions] Just to remind everyone, certain matters discussed … Continue Reading
Read nowTranscripts - Operator Thank you for standing by. Welcome to Nkarta Conference Call to review the clinical update for NKX101. At this time, all participants are in … Continue Reading
Read nowTranscripts - Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics conference call to present the positive Phase II results of … Continue Reading
Read nowTranscripts - Participants -Matt Gline, CEO -Mayukh, Sukhatme, President & CIO -Frank Torti, Chair Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to … Continue Reading
Read nowTranscripts - Participants Richard Aranda, CMO Fahim Hasnain, CEO Bryan Giruado, CFO Fahim Hasnain, CEO We’re very excited about getting our phase three off the ground. We’re … Continue Reading
Read nowInsights - Day One (DAWN) announced a $150M raise priced at $13/share after presenting additional data at ASCO 2023. Importantly, the company formed a regulatory pathway in … Continue Reading
Premium
